SCHEMBL2128127

SCHEMBL2128127

C=C(C)C(=O)OC1CC(=O)NC1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 4/20 0.35
DDB1 Q16531 3/20 0.35
MAP3K14 Q99558 1/20 0.34
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.31
GPX4 P36969 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
HTT P42858 2/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
RECQL P46063 1/20 0.30
RAB9A P51151 1/20 0.30
ATM Q13315 1/20 0.30
MEN1 O00255 1/20 0.30
APEX1 P27695 1/20 0.30
KMT2A Q03164 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57232 0.82 MAP3K14 (0.39) CRBNDDB1MAP3K14LMNATDP1
SCHEMBL10597719 0.77 MAP3K14 (0.38) CRBNDDB1MAP3K14NPC1
SCHEMBL4396268 0.76 CRBN (0.35) CRBNDDB1MAP3K14LMNATDP1
SCHEMBL7264550 0.76 MAP3K14 (0.40) CRBNDDB1MAP3K14LMNATDP1
SCHEMBL3949247 0.76 MAP3K14 (0.40) CRBNDDB1MAP3K14ALDH1A1LMNA
SCHEMBL756451 0.75 CRBN (0.38) CRBNDDB1MAP3K14ALDH1A1TDP1
SCHEMBL7530544 0.74 MAP3K14 (0.39) CRBNDDB1MAP3K14LMNATDP1
SCHEMBL2782193 0.74 MEN1 (0.40) CRBNDDB1MAP3K14LMNATDP1
SCHEMBL7255757 0.74
SCHEMBL9249468 0.74 MAP3K14 (0.35) CRBNDDB1MAP3K14TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130177976-A1 COMBINATION OF CATIONIC POLYMERS AND POLYSACCHARIDES NANOPARTICLES AS A GENE CARRIER KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-07-11 US claimed
US-20130136714-A1 FUNCTIONALIZED POLYMER NANOPARTICLES AND THE PHARMACEUTICAL USE THEREOF KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-05-30 US claimed
EP-1899434-A1 FLUORESCENT POLYMERS SOLUBLE IN AN AQUEOUS SOLUTION AND A METHOD FOR THE PRODUCTION THEREOF bioMérieux S.A. (FR) 2008-03-19 EP claimed
WO-2007003781-A1 FLUORESCENT POLYMERS SOLUBLE IN AN AQUEOUS SOLUTION AND A METHOD FOR THE PRODUCTION THEREOF BIOMERIEUX S.A. (FR) 2007-01-11 WO claimed
EP-1701741-A2 COMPLEXES HAVING ADJUVANT ACTIVITY Polytherics Limited (GB) 2006-09-20 EP claimed
WO-2005065712-A2 COMPLEXES HAVING ADJUVANT ACTIVITY POLYTHERICS LIMITED (GB) 2005-07-21 WO claimed
US-20260014186-A1 POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY BATTELLE MEMORIAL INSTITUTE (US) 2026-01-15 US disclosed
US-12433910-B2 Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery BATTELLE MEMORIAL INSTITUTE (US) 2025-10-07 US disclosed
US-20240415865-A1 POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY BATTELLE MEMORIAL INSTITUTE (US) 2024-12-19 US disclosed
US-12109223-B2 Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery BATTELLE MEMORIAL INSTITUTE (US) 2024-10-08 US disclosed
US-12031128-B2 Rapid design, build, test, and learn technologies for identifying and using non-viral carriers BATTELLE MEMORIAL INSTITUTE (US) 2024-07-09 US disclosed
US-20240189338-A1 POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY BATTELLE MEMORIAL INSTITUTE 2024-06-13 US disclosed
US-20240117339-A1 RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS BATTELLE MEMORIAL INSTITUTE 2024-04-11 US disclosed
EP-0644181-B1 AMINO ACID DERIVATIVE AND USE THEREOF FUJI PHOTO FILM CO LTD (JP) 1996-09-04 EP disclosed
EP-0644181-A1 AMINO ACID DERIVATIVE AND USE THEREOF FUJI PHOTO FILM CO., LTD. (JP) 1995-03-22 EP disclosed
EP-0049860-B1 PROCESS FOR THE PREPARATION OF REACTIVE THYROID GLAND HORMONES T3 AND T4 DERIVATIVES THAT ARE CAPABLE OF COUPLING, AND THEIR USE Roche Diagnostics GmbH (DE) 1984-10-03 EP disclosed
US-4423227-A SILYLATION, ACYLATION BOEHRINGER MANNHEIM GMBH (DE) 1983-12-27 US disclosed
EP-0049860-A1 Process for the preparation of reactive thyroid gland hormones T3 and T4 derivatives that are capable of coupling, and their use Roche Diagnostics GmbH (DE) 1982-04-21 EP disclosed
US-4182695-A Polyamide-fixed biologically active protein BOEHRINGER MANNHEIM GMBH (DE) 1980-01-08 US disclosed
US-4119589-A IMMOBILIZING, IMINOCHLORIDE FORMED BY CHLORINATING DI-SECONDARY AMINE BOEHRINGER MANNHEIM GMBH (DE) 1978-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12031128-B2 Rapid design, build, test, and learn technologies for identifying and using non-viral carriers PHAX, POLRMT, RFTN1 CRBN 1489/4885DDB1 543/4885MAP3K14 2430/4885
US-12109223-B2 Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery POLN, POLRMT, MAVS CRBN 1619/4885DDB1 275/4885MAP3K14 4050/4885
US-12433910-B2 Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery POLN, POLRMT, MAVS CRBN 1619/4885DDB1 275/4885MAP3K14 4050/4885
US-20240117339-A1 RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS PHAX, POLRMT, RFTN1 CRBN 1489/4885DDB1 543/4885MAP3K14 2430/4885
US-20240415865-A1 POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY POLN, POLRMT, MAVS CRBN 1619/4885DDB1 275/4885MAP3K14 4050/4885
US-20240189338-A1 POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY POLN, POLRMT, MAVS CRBN 1619/4885DDB1 275/4885MAP3K14 4050/4885
US-20260014186-A1 POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY POLRMT, FUS, POLM CRBN 2545/4885DDB1 250/4885MAP3K14 4137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.